[6] [7] These medicationsincluding semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)bind to GLP-1 receptors distributed throughout multiple organ systems, triggering a cascade of metabolic effects
NIAAA grant R21AA026931 and NIDA grant R21DA047663 (C.H.)
Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice
However, for those struggling to lose weight with lifestyle adjustments alone, semaglutide can significantly improve outcomes
In addition to a 2030% reduction in albuminuria compared to placebo, GLP-1 receptor agonists (GLP-1RAs) decelerate the decline of estimated glomerular filtration rate (eGFR) by 12 mL/min/1.73m2 per year relative to usual therapy (Granata et al
Ludvik B et al